Product Code: RP-ID-10293979 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10293979
Market Overview:
In Vitro Diagnostics Market, By Application (Immunochemistry, Hematology, Microbiology, Molecular Diagnostics, Clinical Chemistry, Hemostasis, and others), by End Use (Instruments and Reagents), And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025
REPORT HIGHLIGHT
The in vitro diagnostics market is estimated to represent a global market of USD 58.78 billion by 2016 with growth rate of 6.2%. In-Vitro Diagnostics market covers the market understanding for the instruments and reagents that can be used for the diagnosis of chronic disease conditions. As per the U.S. FDA, in vitro diagnostics is defined as the types of instruments, reagents and systems which is intended to be used for the diagnosis of chronic disease conditions. This technique is intended for the detection and analysis of collected, prepared and examine specimens extracted from the human body.
In vitro diagnostics are considered under medical devices category under section 210(h) of the United States Federal Food, Drug, and Cosmetic Act. This devices are subjected to pre-market and post-market approval under the Clinical Laboratory Improvement Amendments act (CLIA ’88) of 1988.
In terms of application segment covers the market analysis for Immunochemistry, Hematology, Microbiology, Molecular Diagnostics, Clinical Chemistry, Hemostasis, and others. Products segment is divided as instruments and reagents. Reagents segment recorded highest share with more than 75% share of the total market. Growing use of reagents in IVD test tools coupled with rising usage of its drives the market growth.
Companies such as Siemens, Danaher Corporation, Roche Diagnostics, bioMérieux, and Abbott are profiles in the report. Companies are engaged in rigorous research and development initiatives to expand their presence in market. In September 2016, Danaher Corporation acquired Cepheid for more than USD 4 billion which have helped company to expand its market share in IVD market significantly. Cepheid is a leading provider of molecular diagnostics kits and tests. Danaher’s president stated that the engagement with Cepheid will help company to strengthen its business into disease diagnosis segment.
The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.
The years considered for the study are:
Historical Year – 2014 & 2015
Base Year – 2015
Estimated Year – 2016
Projected Year – 2025
TARGET AUDIENCE
Traders, Distributors, And Suppliers
Manufacturers
Hospitals
Government and Regional Agencies and Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY APPLICATION
Immunochemistry
Hematology
Microbiology
Molecular Diagnostics
Clinical Chemistry
Hemostasis
Others
MARKET, BY PRODUCTS
Instruments
Reagents
MARKET, BY REGION
North America
Europe
Asia Pacific
Rest of the World
MARKET, BY COUNTRY
Further Breakdown of The North America Market
U.S.
Canada
Further Breakdown of The Europe Market
Germany
France
Rest of Europe
Further Breakdown of The APAC Market
India
China
Rest of APAC
Further Breakdown of The Rest of the World Market
Middle East and Africa
Latin America
Related Reports
Proof of Quality & Reliability
